ReTaMed Holding ApS: Financial statements 2023
CVR: 39565692
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ReTaMed Holding ApS (CVR 39565692) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,208 and a net result of DKK -21,954 compared with DKK -31,277 the year before. Equity in the 2023 report amounted to DKK -8,656.
- Gross Profit
- DKK -7,208
- Profit/Loss
- DKK -21,954
- Equity
- DKK -8,656
- Total Assets
- DKK 201,657
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7K | -22K | -9K | - |
| 2022 | - | -9K | -31K | 21K | 0 |
| 2021 | - | -8K | -76K | 52K | 0 |
| 2020 | - | -7K | -263K | 128K | 0 |
| 2019 | - | -7K | -176K | 392K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ReTaMed Holding ApS has published its annual report for 2022. Gross profit came to DKK -8,802, and the net result was DKK -31,277.
About ReTaMed Holding ApS
ReTaMed Holding ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ReTaMed ApS. The management consists of Henrik Fomsgaard-Knudsen. The company is owned by Henrik Fomsgaard-Knudsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,022 and a net result of DKK -2,522 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000.